Epidermal growth factor contamination and concentrations of intact human chorionic gonadotropin in commercial preparations

This publication has 9 references indexed in Scilit:

• Prion transmission in blood and urine: what are the implications for recombinant and urinary-derived gonadotrophins?
  Human Reproduction, 2002
• Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (OvidrelR) to urinary hCG (ProfasiR) for induction of final follicular maturation in in vitro fertilization–embryo transfer
  Fertility and Sterility, 2001
• Eosinophil derived neurotoxin (EDN) levels in commercial human urinary preparations of glycoprotein hormones
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 1999
• Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone
  Nature, 1995
• The detection and isolation of protease activity associated with purified preparations of human chorionic gonadotropin.
  Endocrinology, 1993
• Epidermal growth factor in urine of pregnant women and in amniotic fluid throughout pregnancy
  Gynecological Endocrinology, 1990
• Characterization of epidermal growth factor-related proteins from human urinary chorionic gonadotrophin
  Journal of Endocrinology, 1989
• Heterogeneity of Proteins in Commercial Preparations of Human Chorionic Gonadotropin (hCG) Demonstrated by Western Blotting
  American Journal of Reproductive Immunology, 1988
• Alteration of the growth of cytomegalovirus and herpes simplex virus type 1 by epidermal growth factor, a contaminant of crude human chorionic gonadotropin preparations.
  Journal of Clinical Investigation, 1978